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Background: Ocular syphilis is reemerging as an important cause of uveitis in the new era of common co-infection
with HIV. This study will reveal the clinical and laboratory characteristics in the group of individuals co-infected with
ocular syphilis and HIV compared with HIV-negative individuals. In this retrospective observational case series,
medical records of patients diagnosed with ocular syphilis with serologic support from 2008 to 2014 were
reviewed. Ocular and systemic manifestation and laboratory profiles were reviewed.
Results: Twenty-nine eyes of 16 consecutive patients (10 HIV-positive and 6 HIV-negative) were included. All
patients were males, and mean age of onset for ocular syphilis was 43 (mean 42.65 ± 13.13). In both HIV-positive
and HIV-negative groups, ocular manifestations of syphilis were variable including anterior uveitis (4 eyes),
posterior uveitis (8 eyes), panuveitis (13 eyes), and isolated papillitis (4 eyes). In HIV-positive patients, panuveitis
was the most common feature (12/18 eyes, 67 %) and serum rapid plasma reagin (RPR) titers were significantly
higher (range 1:64–1:16,348; mean 1:768; p = 0.018) than in HIV-negative patients. Upon the diagnosis of ocular
syphilis in HIV-positive patients, HIV-1 viral load was high (median 206,887 copies/ml) and CD4 cell count ranged
from 127 to 535 cells/ml (mean 237 ± 142; median 137). Regardless of HIV status, cerebrospinal fluid (CSF) exam
was frequently abnormal: positive CSF fluorescent treponemal antibody absorption (FTA-ABS) or Venereal Disease
Research Laboratory (VDRL) test results in seven patients or either elevated CSF WBC count or elevated CSF
protein in six patients.
Conclusions: Our results reveal that the patients with ocular syphilis with high serum RPR titers may have
concomitant HIV infection requiring further testing for HIV status and ocular syphilis is likely associated with the
central nervous system involvement and therefore needs to be managed according to the treatment
recommendations for neurosyphilis.
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Syphilis is a multi-systemic infection caused by the spiro-
chete Treponema pallidum. Since the introduction of
antibiotics, notably penicillin, the incidence of syphilis de-
creased dramatically and reached its lowest recorded level
in the year 2000 [1]. However, the number of syphilis
cases has steadily increased since then. This increase was
attributed to syphilis outbreaks in multiple regions of the
USA including Southern California [2]. In the recent out-
breaks, high rates of HIV co-infection were documented,
ranging from 20 to 70 % [1–4]. Kaiser Permanente,* Correspondence: narsing.rao@med.usc.edu
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the Creative Commons license, and indicate ifNorthern California, reported syphilis incidence stood at
62.3 per 1000 person-years in the HIV group vs 0.8 per
1000 person-years in the non-HIV group. Statistical
analysis adjusted for age, gender, and HIV status deter-
mined that HIV-positive individuals had an 86 times
higher syphilis risk [5].
Reportedly, neurosyphilis, one of the most devastating
complications of syphilis, is now more commonly seen in
patients infected with HIV than was previously reported.
Furthermore, neurological manifestations in syphilis have
changed; there is now a higher prevalence and faster pro-
gress to the early forms of neurosyphilis such as acute
meningitis and meningovasculitis than the later form such
as paretic neurosyphilis or tabes dorsalis [6, 7]. In addition,
reduced sensitivity and specificity of syphilis serology anddistributed under the terms of the Creative Commons Attribution 4.0
rg/licenses/by/4.0/), which permits unrestricted use, distribution, and
e appropriate credit to the original author(s) and the source, provide a link to
changes were made.
Fig. 1 Newly diagnosed ocular syphilis patients by year
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syphilis more challenging were reported in HIV co-infected
patients [8, 9].
Ocular inflammation was observed up to one third of all
neurosyphilis patients [10]. Although numerous studies
on ocular syphilis have been reported, there are limited
data about HIV-related risk factors such as HIV viral load
or CD4+ cell count as they relate to syphilis serology and
CSF laboratory findings. This is particularly important be-
cause ocular syphilis can present in the absence of neuro-
logical manifestations [10]. As such, in this new era of
reemergence of syphilis associated with HIV co-infection,
the present study aims to determine the clinical and la-
boratory characteristics of ocular syphilis in HIV-positive
patients compared to HIV-negative patients.
Methods
Data collection
The clinical, laboratory, and ocular image records of pa-
tients with ocular syphilis from January 2008 through
April 2014 at the Los Angeles County Medical Center
were retrospectively reviewed. Institutional review board of
the University of Southern California approved this study.
Patients with various ocular manifestations with positive
non-treponemal rapid plasma reagin (RPR) and treponemal
fluorescent treponemal antibody absorption (FTA-ABS)
assay serologies were included. Historical details included
duration of ocular symptoms, age, ethnicity, gender, and
sexual orientation. All patients underwent a complete phys-
ical examination and HIV screening regardless of known
previous history. Serologic test results, CSF analyses, and
fluorescein angiography images were also examined. In
addition, CNS imaging was also performed. All of these
findings were compared between HIV-positive patients
and HIV-negative patients. Type of uveitis was classified
into anterior uveitis, intermediate uveitis, posterior uveitis,
and panuveitis following the Standardization of Uveitis
Nomenclature (SUN) Working Group schema.
Statistical analysis
The significance of syphilis serology findings on serum
and CSF was determined using univariate analysis. Serum
RPR titer was maintained as a continuous variable, and
the Mann-Whitney U test was used to examine the associ-
ation between HIV status and RPR titer. However, CSF
serology was reported as a dichotomous variable; patients
with negative results for both the FTA-ABS and Venereal
Disease Research Laboratory (VDRL) tests were consid-
ered CSF-negative, while patients with either a positive
FTA-ABS or positive VDRL were considered CSF-positive.
Fisher’s exact test was then used to examine the associ-
ation between HIV status and CSF status.
Data were managed and analyzed using SPSS version




Sixteen consecutive patients (10 HIV-positive vs 6 HIV-
negative) with 29 involved eyes were diagnosed with
ocular syphilis. Among these patients, the number of
HIV-positive patients presenting with ocular syphilis has
increased over 2012 to 2014 from its level from 2008 to
2011 (Fig. 1). All patients were males, and mean age of
onset was 43 (mean 42.65 ± 13.13). Seven patients out of
10 HIV-positive patients were men who have sex with
men (MSM).
Ocular manifestation
Regardless of HIV status, ocular findings of ocular syph-
ilis were variable including anterior uveitis (4 eyes), pos-
terior uveitis (8 eyes), panuveitis (13 eyes), and isolated
papillitis (4 eyes). However, panuveitis was the most
common diagnosis (12/18 eyes, 67 %) in HIV-positive
patients whereas posterior uveitis was the predominant
diagnosis (6/11 eyes, 55 %) in HIV-negative patients
(Table 2). In HIV-positive patients, either isolated or
combined disc swelling was noted in 14 eyes in contrast
to only 1 eye in HIV-negative patients.
All patients were treated with intravenous (IV) benzyl
penicillin 18–24 MU/day for 10 to 14 days. Most of the
patients responded to intravenous penicillin with rela-
tively good visual outcome (Table 2).
Systemic manifestations
All patients were sent for complete neurologic work-up,
and 15 of 16 patients underwent lumbar puncture (LP)
for CSF analyses. Among 10 HIV-positive patients, six
patients (cases 2, 3, 4, 5, 6, and 9) were positive for ei-
ther FTA-ABS or VDRL on CSF serology. Three patients
(cases 2, 5, and 6) presented with a maculopapular skin
rash, alopecia of the scalp, and/or oral ulcers, and one
patient (case 7) presented with headache and new onset
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showed cerebral volume loss on MRI. Among six HIV-
negative patients, one patient (case 12) presented with
oculomotor and facial nerve palsies and one another pa-
tient (case 16) presented with tabes dorsalis, with positive
VDRL on CSF exam. Two other patients (cases 12 and 15)
from the HIV-negative group showed diffuse cerebral vol-
ume loss on either brain MRI or CT studies although no
other focal neurologic sign was observed. Inflammatory
changes in the meninges were not observed radiographic-
ally in any of these patients.
Laboratory profiles
All patients were positive for both the RPR and FTA-ABS
serology tests. Significantly, higher serum RPR titers were
found in HIV-positive patients (range 1:64–1:16,348) than
in HIV-negative patients (range 1:2–1:8, except one pa-
tient with 1:2048) (p = 0.018) (Fig. 2). The HIV-negative
patient with high serum RPR titer (case 16) presented with
tabes dorsalis in addition to isolated bilateral papillitis. In
all of the HIV-positive patients and two out of four HIV-
negative patients who had follow-up serum RPR titers, the
elevated non-treponemal titers were decreased following
IV penicillin treatment (Table 2).
In HIV-positive patients, 9 out of 10 patients underwent
LP and CSF FTA-ABS or VDRL was positive in 6 patients
(2 positive CSF VDRL and 4 positive CSF FTA-ABS) and
CSF WBC count was elevated in 1 of the remaining 3
patients (>20 cells/mm3) [11]. All of the HIV-negative
patients underwent LP, and in one of the six patients, CSF
VDRL was positive. On the other hand, in five out of the
six patients, either CSF protein (>40 mg/dl) or CSF WBC
count (>5 cells/mm3) was elevated [12]. Due to the low
numbers of patients in the study, however, this trend of
more frequent positive CSF FTA-ABS or VDRL being
found in HIV-positive patients (60 % in HIV-positive vs
16 % in HIV-negative) was not statistically significant
(p = 0.145) (Table 1).
At the onset of ocular symptoms in HIV-positive pa-
tients, HIV-1 viral load ranged from 24,561 to >5,000,000
copies/ml (median 206,887; mean 1,008,779 ± 17,306)
and CD4 cell count ranged from 127 to 535 cells/mlFig. 2 Serum RPR titers at diagnosis by HIV status(mean 237 ± 142) (Table 1). Six of 10 HIV-positive pa-
tients were newly diagnosed with HIV during this time.
Of the remaining four patients with previously diag-
nosed HIV, three of them (cases 7, 8, and 10) were on
HAART treatment.
Discussion
In our study, among 16 patients who were diagnosed with
ocular syphilis, 10 patients were HIV-positive whereas 6
patients were HIV-negative. The yearly number of HIV-
positive patients with ocular syphilis has increased over its
2008 to 2011 level in the years 2012–2014 (Fig. 1). Such an
increase is also supported by a recent report from Centers
for Disease Control and Prevention (CDC) revealing sig-
nificantly increased primary and secondary syphilis cases
since 2009 and a high rate of HIV co-infection [1]. The
2010 Early Syphilis Annual Surveillance Report for Los
Angeles County reported that, among 516 newly diagnosed
with early syphilis, 58 % of the cases were HIV infected [3].
Furthermore, in our study, among 10 HIV-positive pa-
tients, six of those patients were newly diagnosed with HIV
during the assessment of their ocular syphilis. Similarly,
Kunkel reported 24 ocular syphilis patients presented from
1998 to 2006. In their series, 11 patients were noted to be
HIV-positive and 7 out of 11 patients were newly diag-
nosed with HIV [6]. Moreover, in a CDC report with 147
patients with neurosyphilis from four major cities from
2002 to 2004, neurosyphilis was the sentinel presentation
of HIV in 49 patients (33 %) [13]. These results and our
series suggest that HIV-positive patients may often present
with ocular syphilis before the HIV status is known. There
have been a number of hypotheses regarding increased
dual infection of HIV and syphilis. Historically, syphilis
has similar epidemiologic risk factors with HIV, par-
ticularly among MSM. In addition, HIV may modify the
natural course of syphilis in these patients by modulat-
ing immunologic response to T. pallidum in a way that
may increase the propensity of the disease to progress
to neurosyphilis [14].
While syphilis may affect the eye in various ways, uveitis
is the most common ocular presentation [7]. The diagnosis
of ocular syphilis based on ophthalmic findings, however,
is often challenging due to lack of pathognomonic findings.
In our study, regardless of HIV status, ocular findings of
syphilis were variable including anterior uveitis (4 eyes),
posterior uveitis (8 eyes), panuveitis (13 eyes), and isolated
papillitis (4 eyes). This implies that a high index of suspi-
cion of syphilis is required on screening for etiologic diag-
nosis in various types of uveitis. For those 18 eyes in the
HIV-positive group, the majority (67 %) had panuveitis
whereas for those 11 eyes in the HIV-negative group, the
majority (55 %) had posterior uveitis at initial presentation
(Table 2). Such findings may suggest that intraocular in-
flammation could be more severe in HIV-positive patients
Table 1 Syphilis serology test of serum and CSF in HIV-positive and HIV-negative patients
Age/gender/race HIV Serology CSF Pa; Cb CD4c HIV-1 viral loadd Last RPR
1 40/M/B + RPR+ (1:64); FTA-ABS+ NRP:30; W:21 535 24,561 NR (5 years)
2 43/M/H + RPR+ (1:1024); FTA-ABS+ FTA-ABS+P:46; W:4 137 >5,000,000 1:64 (15 months)
3 20/M/H + RPR+ (1:2048); FTA-ABS+ FTA-ABS+P:97; W:189 376 189,089 1:16 (10 months)
4 28/M/W + RPR+ (1:16,384); FTA-ABS+ VDRL+P:36; W:7 127 496,559 1:16 (1 year)
5 27/M/H + RPR+ (1:512); FTA-ABS+ VDRL+P:79; W:18 134 NA NA
6 48/M/W + RPR+ (1:64); FTA-ABS+ FTA-ABS+P:43; W:37 124 224,685 NA
7 49/M/H + RPR+ (1:64); FTA-ABS+ NRP:25; W:3 NA NA 1:8 (4 months)
8 25/M/B + RPR+ (1:1024); FTA-ABS+ NRP:20; W:0 134 NA NA
9 46/M/H + RPR+ (1:1024); FTA-ABS+ FTA-ABS+P:23; W:1 371 117,779 1:64 (1 month)
10 50/M/H + RPR+ (1:256); FTA-ABS+ NANA 201 NA NA
11 59/M/H − RPR+ (1:2); FTA-ABS+ NRP:543; W:2 1:2 (1 month)
12 63/M/H − RPR+ (1:2); FTA-ABS+ NRP:63; W:1 NA
13 51/M/B − RPR+ (1:2); FTA-ABS+ NRP:48; W:0 NA
14 52/M/H − RPR+ (1:2); FTA-ABS+ NRP:50; W:3 NR
15 58/M/B − RPR+ (1:8); FTA-ABS+ NRP:20; W:1 1:8 (6 months)
16 55/M/O − RPR+ (1:2048); FTA-ABS+ VDRL+P:86; W:6 1:128 (1 year)
B black, W white, H Hispanic, M male, RPR rapid plasma reagin, FTA-ABS fluorescent treponemal antibody absorption, NR non-reactive, NA not available
aCSF protein mg/dl
bCSF WBC count cell/ml
ccell/ml
dcopies/ml
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posterior uveitis is limited to the choroid. Previously,
Hughes reported that retinitis with panuveitis was the most
common ocular presentation regardless of HIV status and
the strong association between HIV co-infection and syph-
ilitic retinitis (100 % HIV-positive vs 14 % in HIV-negative)
suggesting that HIV infection may modulate the severity of
ocular syphilis [15]. Tran also found a high frequency of
posterior uveitis in the presence of HIV and syphilis co-
infection [16]. Similarly to our study, both Hughes and
Tran suggested that syphilitic ocular inflammation of syph-
ilis in HIV-infected patients seems to diffuse [15, 16]. The
latest British Ocular Syphilis Study (BOSS) also reported
that HIV-positive patients had higher rates of panuveitis
than HIV-negative patients, although there were no signifi-
cant differences in presenting or posttreatment visual acu-
ity between two groups [17].
Our study also shows significantly higher serum RPR ti-
ters found in HIV-positive patients (range 1:64–1:16,348).
Although it was previously suggested that the complex
interaction of syphilis and HIV infection may cause non-
treponemal tests such as VDRL or RPR serology to be-
come falsely positive or negative, in general it has been
suggested that non-treponemal test titers may be higher
among HIV-positive patients than among HIV-negative
patients [15–23]. Nevertheless, the high serum RPR titers
in our HIV-positive patients are unlikely to be falsely posi-
tive because the diagnosis of ocular syphilis of all of ourpatients was supported by positive serum treponemal
tests. In addition, the patients’ high RPR titers decreased
following IV penicillin treatment in those who were
retested, and ocular inflammation and vision improved
after treatment. While HIV is considered to be one of the
important causes of a false-positive reaction to serum
non-treponemal test, in HIV-positive patients, a positive
non-treponemal test requires careful evaluation by pairing
it with a treponemal test when ocular syphilis is clinically
suspected and high baseline serum RPR titers are present.
The non-treponemal test is also useful to monitor the re-
sponse to treatment in addition to ocular examination.
Our study also demonstrates frequent positive CSF
FTA-ABS or VDRL test results in HIV-positive patients
(60 % in HIV-positive vs 16 % in HIV-negative); how-
ever, due to the low numbers in the study, this was not
found to be statistically significant. In our study, all pa-
tients except for one underwent lumbar puncture for
CSF analysis. While CDC recommends CSF examination
only if a patient has either neurological or ophthalmic
signs or symptoms, evidence of active tertiary syphilis,
or serologic treatment failure, whether or not they are
infected with HIV, the criteria for CSF exam is still con-
troversial [24]. Other guidelines still propose LP in HIV-
positive patients with RPR titers of ≥1:32 or a CD4 cell
count of <350 cells/ml [25, 26]. Others recommend that
any HIV patient with syphilis should have an LP regard-
less of the presence of neurologic symptoms [26]. In the
Table 2 Clinical findings of ocular syphilis in HIV-positive and HIV-negative patients
Initial VA Type of uveitis Treatment Final VA FU duration
1
OD 20/50 Posterior uveitis
IV PCN × 14 days
OD 20/40
8 years
OS 20/30 Posterior uveitis OS 20/40
2
OD LP Panuveitis
IV PCN × 14 days
OD 20/25
3 years
OS 20/30 Panuveitis OS 20/80
3
OD 20/30 Panuveitis IV PCN × 14 days OD 20/70
2 years
OS 20/40 Panuveitis IM PCN × 3 weeks OS 20/40
4
OD 20/20 None IV PCN × 14 days OD 20/25
10 months
OS 20/200 Panuveitis IM PCN × 3 weeks OS 4 ft/200
5
OD 20/25 Anterior uveitis
IV PCN × 10 days
OD 20/30
1 months
OS 20/40 Panuveitis OS 20/40
6
OD 20/150 Panuveitis IV PCN × 14 days OD 20/25
4 months
OS HM Panuveitis IM PCN × 3 weeks OS 20/80
7
OD 20/25 Papillitis IV ceftriaxone × 14 days OD 20/40
4 months
OS 20/20 Papillitis Doxycycline po × 21 days OS 20/40
8
OD 20/30 Anterior uveitis
IV PCN × 14 days
OD 20/40
4 months
OS 20/30 Anterior uveitis OS 20/25
9
OD 20/30 Panuveitis
IV PCN × 14 days
OD 20/30
1 months
OS 20/30 Panuveitis OS 20/40
10
OD 20/150 Panuveitis
IV PCN × 14 days
OD 20/70
1 months
OS HM Panuveitis OS 8/200
11
OD 20/400 Posterior uveitis
IV PCN × 14 days
OD 20/150
7 months
OS 20/200 Posterior uveitis OS 20/150
12










Anterior uveitis IV PCN × 12 days
OD prosthesis
1 months
OS 20/25 OS 20/40
14
OD 20/30 None
IV PCN × 10 days
OD 20/25
3 years
OS 8 ft/200 Panuveitis OS 20/400
15




OS HM Posterior uveitis OS NA
16
OD NLP Pale disc
IV PCN × 14 days
OD NLP
12 months
OS 20/60 Papillitis OS 20/40
VA visual acuity, FU follow-up, LP light perception, HM hand motion, NLP no light perception, PCN, penicillin
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ities such as elevated CSF protein or white blood cell
count or positive CSF VDRL or FTA-ABS results are
useful to diagnose neurosyphilis. In our study, 6 of 10
HIV patients were positive for CSF VDRL or FTA-ABS.
Since false-positive CSF VDRL or FTA-ABS values are
very rare, these findings suggest the involvement of the
central nervous system by syphilis in patients with HIV.
However, none of these patients showed additional neuro-
logic manifestations on clinical and radiographic exam.
These findings suggest that ocular syphilis can present as
a solitary manifestation of neurosyphilis without otherovert neurologic impairments. On the other hand, our
study showed that CSF exam of four out of five HIV-
negative patients showed negative CSF VDRL or FTA-
ABS but elevated CSF protein or CSF WBC count in three
out of four patients. These findings in the HIV-negative
group also may suggest CNS involvement or at least a
compromised blood brain barrier because CSF VDRL or
FTA-ABS is considered to be highly specific yet low sensi-
tivity tests (22 to 69 %) and elevated CSF protein or WBC
count were not confounded by other conditions such as
HIV [11]. In this context, regardless of HIV status, our
study supports the need for CSF analyses and parenteral
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these study results support the recent clinical advisory
from CDC on ocular syphilis. The CDC reported 24
newly diagnosed ocular syphilis cases from California
and Washington since December 2014, recommended
lumbar puncture with CSF examination in any patients
with syphilis and ocular complaint, and recommended
management of ocular syphilis according to the treat-
ment recommendations for neurosyphilis [27]. Current
guidelines from CDC on the treatment of neurosyphilis
are either intravenous aqueous crystalline penicillin G
or intramuscular procaine penicillin with probenecid
for 10–14 days [24, 27]. As an alternative agent, the
United Kingdom (UK) recommended oral doxycycline
400 mg daily for 28 days in patients who are allergic to
penicillin or patients who refuse inpatient intravenous
therapy [28].
Upon diagnosis of ocular syphilis in our HIV-positive pa-
tients, HIV-1 viral load ranged from 24,561 to >5,000,000
copies/ml (median 206,887; mean 1,008,779 ± 17,306) and
this was higher than what was previously reported in
neurosyphilis (median 67,450; range 11,900–113,000)
or in ocular syphilis (mean 145,087.6 ± 166; range
30,321–>500,000) [29–31]. In our study, CD4 cell count
typically ranged from 127 to 535 (mean 237 ± 142). Al-
though syphilis is not an opportunistic infection such
as cryptosporidiosis, cryptococcosis, pneumocystis cari-
nii, or cytomegalovirus (50 < CD4 < 100 cells/ml) and
mycobacterium avium complex (CD4 < 50 cells/ml), our
study suggests that high HIV-1 viral load and relatively
compromised immune status in HIV patients may play
a role in ocular manifestation of syphilis [31].
Conclusions
In the new era of reemergence of ocular syphilis associ-
ated with positive HIV status, we report that ocular syph-
ilis in HIV patients is associated with more severe or
diffuse forms of ocular inflammation such as panuveitis.
Some features may be more common in HIV-positive pa-
tients compared to HIV-negative, such as disc swelling.
These patients may have higher RPR titers and are more
likely to demonstrate CSF VDRL or FTA-ABS positivity
then HIV-negative patients. This emphasizes the import-
ance of testing all new cases of ocular syphilis for HIV.
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